Ramsete: A Single-Arm, Multicenter, Single-Stage Phase II Trial of Rad001 (EVEROLIMUS) in Advanced and Metastatic Silent Neuro-Endocrine Tumours in Europe: Analysis by Tumor Origin | Publicación